Portfolio Holdings Detail for ISIN IE00BZ173V67
Stock Name / Fund iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker 3SUR(EUR) ETF Plus

Holdings detail for EW

Stock Name	Edwards Lifesciences Corp
Ticker	EW(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US28176E1082
LEI	YA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen: Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings: Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab: Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW): Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research: Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00: Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW): J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW): Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC: Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW): Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist) EW holdings

Date	Number of EW Shares Held	Base Market Value of EW Shares	Local Market Value of EW Shares	Change in EW Shares Held	Change in EW Base Value	Current Price per EW Share Held	Previous Price per EW Share Held
2025-09-26 (Friday)	168,738	USD 12,866,273	USD 12,866,273
2025-09-25 (Thursday)	168,986	USD 12,719,576	USD 12,719,576	0	USD 103,081	USD 75.27	USD 74.66
2025-09-24 (Wednesday)	168,986	USD 12,616,495	USD 12,616,495
2025-09-18 (Thursday)	169,254	USD 12,617,886	USD 12,617,886	-250	USD -128,815	USD 74.55	USD 75.2
2025-09-17 (Wednesday)	169,504	USD 12,746,701	USD 12,746,701	0	USD 18,646	USD 75.2	USD 75.09
2025-09-16 (Tuesday)	169,504	USD 12,728,055	USD 12,728,055	0	USD -162,724	USD 75.09	USD 76.05
2025-09-15 (Monday)	169,504	USD 12,890,779	USD 12,890,779	0	USD -257,646	USD 76.05	USD 77.57
2025-09-12 (Friday)	169,504	USD 13,148,425	USD 13,148,425	0	USD -74,582	USD 77.57	USD 78.01
2025-09-11 (Thursday)	169,504	USD 13,223,007	USD 13,223,007	0	USD -45,766	USD 78.01	USD 78.28
2025-09-10 (Wednesday)	169,504	USD 13,268,773	USD 13,268,773

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE00BZ173V67

Show aggregate share trades of EW

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-18 SELL -250 74.550* 73.73 Profit of 18,434 on sale
2025-09-04 SELL -2,480 80.960* 73.63 Profit of 182,598 on sale
2025-08-21 SELL -504 81.160* 73.42 Profit of 37,003 on sale
2025-08-20 SELL -630 81.390* 73.38 Profit of 46,226 on sale
2025-08-18 SELL -381 78.300* 73.32 Profit of 27,934 on sale
2025-08-12 SELL -2,159 76.930* 73.27 Profit of 158,200 on sale
2025-08-07 SELL -1,524 77.930* 73.19 Profit of 111,546 on sale
2025-08-04 SELL -254 80.090* 73.12 Profit of 18,572 on sale
2025-07-31 SELL -254 79.310* 73.05 Profit of 18,554 on sale
2025-07-30 SELL -1,651 81.160* 73.00 Profit of 120,527 on sale
2025-07-29 SELL -889 80.470* 72.96 Profit of 64,861 on sale
2025-07-28 SELL -1,143 78.490* 72.93 Profit of 83,356 on sale
2025-07-22 SELL -127 76.300* 72.87 Profit of 9,254 on sale
2025-07-18 BUY 122 76.490* 72.82
2025-07-17 BUY 127 76.180* 72.80
2025-07-16 SELL -1,016 76.140* 72.78 Profit of 73,946 on sale
2025-07-15 SELL -762 76.810* 72.76 Profit of 55,441 on sale
2025-07-10 BUY 756 78.800* 72.72
2025-07-09 SELL -630 77.190* 72.69 Profit of 45,797 on sale
2025-07-08 SELL -3,428 76.390* 72.67 Profit of 249,114 on sale
2025-06-30 BUY 2,708 78.210* 72.53
2025-06-26 SELL -124 77.150* 72.50 Profit of 8,990 on sale
2025-06-24 SELL -313 75.850* 72.45 Profit of 22,676 on sale
2025-06-20 SELL -2,529 73.830* 72.42 Profit of 183,152 on sale
2025-06-17 SELL -5,285 73.270* 72.39 Profit of 382,603 on sale
2025-06-13 SELL -620 75.150* 72.36 Profit of 44,863 on sale
2025-06-12 BUY 595 75.890* 72.33
2025-06-09 SELL -1,364 76.360* 72.26 Profit of 98,563 on sale
2025-06-06 SELL -357 77.520* 72.22 Profit of 25,784 on sale
2025-06-04 SELL -2,337 77.850* 72.14 Profit of 168,600 on sale
2025-06-03 SELL -615 77.720* 72.10 Profit of 44,344 on sale
2025-05-30 BUY 4,985 78.220* 72.02
2025-05-27 SELL -120 76.220* 71.91 Profit of 8,629 on sale
2025-05-23 SELL -1,560 74.990* 71.86 Profit of 112,101 on sale
2025-05-21 SELL -600 76.100* 71.80 Profit of 43,083 on sale
2025-05-19 SELL -228 78.040* 71.71 Profit of 16,350 on sale
2025-05-15 SELL -240 76.880* 71.62 Profit of 17,188 on sale
2025-05-14 SELL -240 76.750* 71.58 Profit of 17,178 on sale
2025-05-13 SELL -120 75.500* 71.55 Profit of 8,585 on sale
2025-05-12 SELL -360 74.800* 71.52 Profit of 25,747 on sale
2025-05-09 SELL -117 73.680* 71.50 Profit of 8,366 on sale
2025-05-08 SELL -1,440 74.630* 71.48 Profit of 102,924 on sale
2025-05-01 SELL -3 75.180* 71.32 Profit of 214 on sale
2025-04-30 SELL -960 75.490* 71.28 Profit of 68,428 on sale
2025-04-28 SELL -4,680 75.540* 71.20 Profit of 333,202 on sale
2025-04-25 BUY 600 76.040* 71.15
2025-04-23 SELL -242 70.460* 71.12 Profit of 17,212 on sale
2025-04-17 BUY 120 71.530* 71.14
2025-04-14 SELL -240 69.870* 71.15 Profit of 17,077 on sale
2025-04-11 BUY 2,828 69.400* 71.17
2025-04-10 SELL -119 68.260* 71.20 Profit of 8,473 on sale
2025-04-09 BUY 357 69.900* 71.21
2025-04-08 SELL -345 67.070* 71.26 Profit of 24,583 on sale
2025-04-07 SELL -1,404 69.000* 71.28 Profit of 100,075 on sale
2025-04-04 SELL -1,170 69.360* 71.30 Profit of 83,419 on sale
2025-04-02 SELL -2,102 72.050* 71.29 Profit of 149,853 on sale
2025-03-31 SELL -351 72.480* 71.27 Profit of 25,016 on sale
2025-03-28 BUY 238 70.910* 71.28
2025-03-27 SELL -15 71.190* 71.28 Profit of 1,069 on sale
2025-03-26 BUY 357 71.090* 71.28
2025-03-25 BUY 595 71.240* 71.28
2025-03-21 SELL -595 70.460* 71.29 Profit of 42,416 on sale
2025-03-20 SELL -119 70.950* 71.29 Profit of 8,484 on sale
2025-03-19 SELL -595 70.900* 71.30 Profit of 42,421 on sale
2025-03-18 SELL -357 70.340* 71.31 Profit of 25,457 on sale
2025-03-14 SELL -595 69.290* 71.34 Profit of 42,447 on sale
2025-03-13 SELL -2,718 67.950* 71.38 Profit of 194,014 on sale
2025-03-12 SELL -119 68.510* 71.42 Profit of 8,499 on sale
2025-03-11 SELL -705 68.390* 71.45 Profit of 50,375 on sale
2025-03-07 SELL -3,205 70.330* 71.51 Profit of 229,178 on sale
2025-03-05 SELL -354 72.850* 71.49 Profit of 25,307 on sale
2025-03-03 BUY 1,180 71.390* 71.49
2025-02-28 SELL -25,210 71.620* 71.49 Profit of 1,802,263 on sale
2025-02-27 SELL -238 71.400* 71.49 Profit of 17,015 on sale
2025-02-26 SELL -2,540 71.960* 71.48 Profit of 181,571 on sale
2025-02-25 SELL -2,142 71.450* 71.49 Profit of 153,121 on sale
2025-02-21 SELL -2,646 73.300* 71.44 Profit of 189,031 on sale
2025-02-20 SELL -4,699 74.710* 71.39 Profit of 335,473 on sale
2025-02-19 SELL -4,914 74.670* 71.34 Profit of 350,582 on sale
2025-02-13 SELL -5,292 76.000* 71.05 Profit of 375,981 on sale
2025-02-12 SELL -1,764 75.820* 70.97 Profit of 125,191 on sale
2025-02-11 SELL -1,134 70.910* 70.97 Profit of 80,481 on sale
2025-02-10 SELL -126 71.100* 70.97 Profit of 8,942 on sale
2025-02-07 SELL -2,646 70.350* 70.98 Profit of 187,811 on sale
2025-02-06 SELL -126 70.990* 70.98 Profit of 8,943 on sale
2025-02-05 SELL -378 72.100* 70.96 Profit of 26,823 on sale
2025-02-04 SELL -1,260 71.330* 70.95 Profit of 89,401 on sale
2025-02-03 SELL -1,512 71.380* 70.95 Profit of 107,269 on sale
2025-01-29 SELL -2,286 71.130* 70.87 Profit of 162,006 on sale
2025-01-28 SELL -2,413 72.560* 70.84 Profit of 170,927 on sale
2025-01-24 SELL -254 68.990* 70.91 Profit of 18,010 on sale
2025-01-23 SELL -254 68.930* 70.95 Profit of 18,021 on sale
2024-12-23 SELL -127 74.810* 70.31 Profit of 8,930 on sale
2024-12-20 SELL -127 74.810* 70.20 Profit of 8,916 on sale
2024-12-19 SELL -756 73.930* 70.11 Profit of 53,000 on sale
2024-12-18 BUY 756 72.810* 70.03
2024-12-17 SELL -252 74.120* 69.92 Profit of 17,621 on sale
2024-12-13 BUY 126 73.320* 69.71
2024-12-11 SELL -635 73.810* 69.59 Profit of 44,192 on sale
2024-12-10 SELL -248 73.390* 69.48 Profit of 17,231 on sale
2024-12-09 BUY 756 70.900* 69.43
2024-12-04 BUY 126 74.200* 69.09
2024-12-02 SELL -476 70.530* 69.00 Profit of 32,844 on sale
2024-11-27 BUY 378 72.070* 68.65
2024-11-26 SELL -504 71.550* 68.52 Profit of 34,534 on sale
2024-11-22 SELL -889 70.480* 68.30 Profit of 60,714 on sale
2024-11-21 SELL -254 70.380* 68.19 Profit of 17,321 on sale
2024-11-19 BUY 630 70.200* 68.00
2024-11-18 SELL -3,051 69.890* 67.89 Profit of 207,143 on sale
2024-11-12 BUY 252 65.810* 68.02
2024-11-07 BUY 2,268 65.840* 68.43
2024-11-05 BUY 1,890 66.690* 68.83
2024-11-04 SELL -504 66.470* 69.07 Profit of 34,811 on sale
2024-11-01 SELL -5,334 67.540* 69.24 Profit of 369,326 on sale
2024-10-31 BUY 1,143 67.010* 69.52
2024-10-30 SELL -375 68.630* 69.65 Profit of 26,117 on sale
2024-10-29 SELL -8,375 69.370* 69.69 Profit of 583,668 on sale
2024-10-28 SELL -250 68.520* 69.93 Profit of 17,481 on sale
2024-10-25 SELL -9,250 69.380* 70.06 Profit of 648,078 on sale
2024-10-24 SELL -1,000 70.350* 69.97 Profit of 69,967 on sale
2024-10-23 SELL -125 70.610* 69.65 Profit of 8,706 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-18	SELL	-250	74.550*	73.73 Profit of 18,434 on sale
2025-09-04	SELL	-2,480	80.960*	73.63 Profit of 182,598 on sale
2025-08-21	SELL	-504	81.160*	73.42 Profit of 37,003 on sale
2025-08-20	SELL	-630	81.390*	73.38 Profit of 46,226 on sale
2025-08-18	SELL	-381	78.300*	73.32 Profit of 27,934 on sale
2025-08-12	SELL	-2,159	76.930*	73.27 Profit of 158,200 on sale
2025-08-07	SELL	-1,524	77.930*	73.19 Profit of 111,546 on sale
2025-08-04	SELL	-254	80.090*	73.12 Profit of 18,572 on sale
2025-07-31	SELL	-254	79.310*	73.05 Profit of 18,554 on sale
2025-07-30	SELL	-1,651	81.160*	73.00 Profit of 120,527 on sale
2025-07-29	SELL	-889	80.470*	72.96 Profit of 64,861 on sale
2025-07-28	SELL	-1,143	78.490*	72.93 Profit of 83,356 on sale
2025-07-22	SELL	-127	76.300*	72.87 Profit of 9,254 on sale
2025-07-18	BUY	122	76.490*	72.82
2025-07-17	BUY	127	76.180*	72.80
2025-07-16	SELL	-1,016	76.140*	72.78 Profit of 73,946 on sale
2025-07-15	SELL	-762	76.810*	72.76 Profit of 55,441 on sale
2025-07-10	BUY	756	78.800*	72.72
2025-07-09	SELL	-630	77.190*	72.69 Profit of 45,797 on sale
2025-07-08	SELL	-3,428	76.390*	72.67 Profit of 249,114 on sale
2025-06-30	BUY	2,708	78.210*	72.53
2025-06-26	SELL	-124	77.150*	72.50 Profit of 8,990 on sale
2025-06-24	SELL	-313	75.850*	72.45 Profit of 22,676 on sale
2025-06-20	SELL	-2,529	73.830*	72.42 Profit of 183,152 on sale
2025-06-17	SELL	-5,285	73.270*	72.39 Profit of 382,603 on sale
2025-06-13	SELL	-620	75.150*	72.36 Profit of 44,863 on sale
2025-06-12	BUY	595	75.890*	72.33
2025-06-09	SELL	-1,364	76.360*	72.26 Profit of 98,563 on sale
2025-06-06	SELL	-357	77.520*	72.22 Profit of 25,784 on sale
2025-06-04	SELL	-2,337	77.850*	72.14 Profit of 168,600 on sale
2025-06-03	SELL	-615	77.720*	72.10 Profit of 44,344 on sale
2025-05-30	BUY	4,985	78.220*	72.02
2025-05-27	SELL	-120	76.220*	71.91 Profit of 8,629 on sale
2025-05-23	SELL	-1,560	74.990*	71.86 Profit of 112,101 on sale
2025-05-21	SELL	-600	76.100*	71.80 Profit of 43,083 on sale
2025-05-19	SELL	-228	78.040*	71.71 Profit of 16,350 on sale
2025-05-15	SELL	-240	76.880*	71.62 Profit of 17,188 on sale
2025-05-14	SELL	-240	76.750*	71.58 Profit of 17,178 on sale
2025-05-13	SELL	-120	75.500*	71.55 Profit of 8,585 on sale
2025-05-12	SELL	-360	74.800*	71.52 Profit of 25,747 on sale
2025-05-09	SELL	-117	73.680*	71.50 Profit of 8,366 on sale
2025-05-08	SELL	-1,440	74.630*	71.48 Profit of 102,924 on sale
2025-05-01	SELL	-3	75.180*	71.32 Profit of 214 on sale
2025-04-30	SELL	-960	75.490*	71.28 Profit of 68,428 on sale
2025-04-28	SELL	-4,680	75.540*	71.20 Profit of 333,202 on sale
2025-04-25	BUY	600	76.040*	71.15
2025-04-23	SELL	-242	70.460*	71.12 Profit of 17,212 on sale
2025-04-17	BUY	120	71.530*	71.14
2025-04-14	SELL	-240	69.870*	71.15 Profit of 17,077 on sale
2025-04-11	BUY	2,828	69.400*	71.17
2025-04-10	SELL	-119	68.260*	71.20 Profit of 8,473 on sale
2025-04-09	BUY	357	69.900*	71.21
2025-04-08	SELL	-345	67.070*	71.26 Profit of 24,583 on sale
2025-04-07	SELL	-1,404	69.000*	71.28 Profit of 100,075 on sale
2025-04-04	SELL	-1,170	69.360*	71.30 Profit of 83,419 on sale
2025-04-02	SELL	-2,102	72.050*	71.29 Profit of 149,853 on sale
2025-03-31	SELL	-351	72.480*	71.27 Profit of 25,016 on sale
2025-03-28	BUY	238	70.910*	71.28
2025-03-27	SELL	-15	71.190*	71.28 Profit of 1,069 on sale
2025-03-26	BUY	357	71.090*	71.28
2025-03-25	BUY	595	71.240*	71.28
2025-03-21	SELL	-595	70.460*	71.29 Profit of 42,416 on sale
2025-03-20	SELL	-119	70.950*	71.29 Profit of 8,484 on sale
2025-03-19	SELL	-595	70.900*	71.30 Profit of 42,421 on sale
2025-03-18	SELL	-357	70.340*	71.31 Profit of 25,457 on sale
2025-03-14	SELL	-595	69.290*	71.34 Profit of 42,447 on sale
2025-03-13	SELL	-2,718	67.950*	71.38 Profit of 194,014 on sale
2025-03-12	SELL	-119	68.510*	71.42 Profit of 8,499 on sale
2025-03-11	SELL	-705	68.390*	71.45 Profit of 50,375 on sale
2025-03-07	SELL	-3,205	70.330*	71.51 Profit of 229,178 on sale
2025-03-05	SELL	-354	72.850*	71.49 Profit of 25,307 on sale
2025-03-03	BUY	1,180	71.390*	71.49
2025-02-28	SELL	-25,210	71.620*	71.49 Profit of 1,802,263 on sale
2025-02-27	SELL	-238	71.400*	71.49 Profit of 17,015 on sale
2025-02-26	SELL	-2,540	71.960*	71.48 Profit of 181,571 on sale
2025-02-25	SELL	-2,142	71.450*	71.49 Profit of 153,121 on sale
2025-02-21	SELL	-2,646	73.300*	71.44 Profit of 189,031 on sale
2025-02-20	SELL	-4,699	74.710*	71.39 Profit of 335,473 on sale
2025-02-19	SELL	-4,914	74.670*	71.34 Profit of 350,582 on sale
2025-02-13	SELL	-5,292	76.000*	71.05 Profit of 375,981 on sale
2025-02-12	SELL	-1,764	75.820*	70.97 Profit of 125,191 on sale
2025-02-11	SELL	-1,134	70.910*	70.97 Profit of 80,481 on sale
2025-02-10	SELL	-126	71.100*	70.97 Profit of 8,942 on sale
2025-02-07	SELL	-2,646	70.350*	70.98 Profit of 187,811 on sale
2025-02-06	SELL	-126	70.990*	70.98 Profit of 8,943 on sale
2025-02-05	SELL	-378	72.100*	70.96 Profit of 26,823 on sale
2025-02-04	SELL	-1,260	71.330*	70.95 Profit of 89,401 on sale
2025-02-03	SELL	-1,512	71.380*	70.95 Profit of 107,269 on sale
2025-01-29	SELL	-2,286	71.130*	70.87 Profit of 162,006 on sale
2025-01-28	SELL	-2,413	72.560*	70.84 Profit of 170,927 on sale
2025-01-24	SELL	-254	68.990*	70.91 Profit of 18,010 on sale
2025-01-23	SELL	-254	68.930*	70.95 Profit of 18,021 on sale
2024-12-23	SELL	-127	74.810*	70.31 Profit of 8,930 on sale
2024-12-20	SELL	-127	74.810*	70.20 Profit of 8,916 on sale
2024-12-19	SELL	-756	73.930*	70.11 Profit of 53,000 on sale
2024-12-18	BUY	756	72.810*	70.03
2024-12-17	SELL	-252	74.120*	69.92 Profit of 17,621 on sale
2024-12-13	BUY	126	73.320*	69.71
2024-12-11	SELL	-635	73.810*	69.59 Profit of 44,192 on sale
2024-12-10	SELL	-248	73.390*	69.48 Profit of 17,231 on sale
2024-12-09	BUY	756	70.900*	69.43
2024-12-04	BUY	126	74.200*	69.09
2024-12-02	SELL	-476	70.530*	69.00 Profit of 32,844 on sale
2024-11-27	BUY	378	72.070*	68.65
2024-11-26	SELL	-504	71.550*	68.52 Profit of 34,534 on sale
2024-11-22	SELL	-889	70.480*	68.30 Profit of 60,714 on sale
2024-11-21	SELL	-254	70.380*	68.19 Profit of 17,321 on sale
2024-11-19	BUY	630	70.200*	68.00
2024-11-18	SELL	-3,051	69.890*	67.89 Profit of 207,143 on sale
2024-11-12	BUY	252	65.810*	68.02
2024-11-07	BUY	2,268	65.840*	68.43
2024-11-05	BUY	1,890	66.690*	68.83
2024-11-04	SELL	-504	66.470*	69.07 Profit of 34,811 on sale
2024-11-01	SELL	-5,334	67.540*	69.24 Profit of 369,326 on sale
2024-10-31	BUY	1,143	67.010*	69.52
2024-10-30	SELL	-375	68.630*	69.65 Profit of 26,117 on sale
2024-10-29	SELL	-8,375	69.370*	69.69 Profit of 583,668 on sale
2024-10-28	SELL	-250	68.520*	69.93 Profit of 17,481 on sale
2024-10-25	SELL	-9,250	69.380*	70.06 Profit of 648,078 on sale
2024-10-24	SELL	-1,000	70.350*	69.97 Profit of 69,967 on sale
2024-10-23	SELL	-125	70.610*	69.65 Profit of 8,706 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	406,402	0	1,881,727	21.6%
2025-09-18	684,520	1,177	3,487,981	19.6%
2025-09-17	484,322	210	1,603,065	30.2%
2025-09-16	811,953	856	2,055,937	39.5%
2025-09-15	611,012	104	1,391,882	43.9%
2025-09-12	982,928	1,100	2,234,227	44.0%
2025-09-11	514,234	828	1,919,009	26.8%
2025-09-10	669,705	149	1,567,941	42.7%
2025-09-09	441,493	0	925,375	47.7%
2025-09-08	632,587	672	1,251,939	50.5%
2025-09-05	334,037	300	934,006	35.8%
2025-09-04	380,318	0	871,931	43.6%
2025-09-03	701,943	459	1,170,966	59.9%
2025-09-02	397,396	53	1,208,872	32.9%
2025-08-29	397,628	800	844,318	47.1%
2025-08-28	604,087	4	1,056,653	57.2%
2025-08-27	493,608	822	875,886	56.4%
2025-08-26	480,268	0	868,213	55.3%
2025-08-25	796,556	0	1,181,258	67.4%
2025-08-22	552,739	1	1,011,678	54.6%
2025-08-21	873,044	798	1,597,742	54.6%
2025-08-20	847,847	38,699	1,560,105	54.3%
2025-08-19	613,349	33	1,256,577	48.8%
2025-08-18	668,719	439	1,642,759	40.7%
2025-08-15	369,455	513	826,723	44.7%
2025-08-14	514,202	6,112	864,593	59.5%
2025-08-13	567,857	299	1,347,264	42.1%
2025-08-12	547,773	12,316	1,428,277	38.4%
2025-08-11	487,823	0	1,152,630	42.3%
2025-08-08	661,697	20	1,224,458	54.0%
2025-08-07	669,931	982	1,297,469	51.6%
2025-08-06	880,028	413	1,551,659	56.7%
2025-08-05	661,933	8	1,592,649	41.6%
2025-08-04	572,165	268	1,310,044	43.7%
2025-08-01	678,028	5,600	1,308,863	51.8%
2025-07-31	831,401	249	1,817,975	45.7%
2025-07-30	1,305,016	693	2,481,808	52.6%
2025-07-29	1,129,154	58	2,399,223	47.1%
2025-07-28	684,101	2,111	2,276,892	30.0%
2025-07-25	1,669,752	920	6,616,259	25.2%
2025-07-24	455,593	0	2,607,898	17.5%
2025-07-23	444,645	0	1,978,110	22.5%
2025-07-22	447,883	511	2,702,925	16.6%
2025-07-21	568,293	27	1,249,727	45.5%
2025-07-18	590,448	59	2,118,402	27.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	3SUR(EUR) ETF Plus